Most adults need 14 to 16 mg of niacinamide (vitamin B3) per day to meet basic nutritional needs. But if you’re taking it for skin, joint health, or other therapeutic reasons, the doses used in clinical research range much higher, from 500 mg to several grams daily. The right amount depends entirely on why you’re taking it.
Basic Daily Requirements
Niacinamide is one of two forms of vitamin B3 (the other is nicotinic acid, commonly called niacin). Your body uses it to convert food into energy and to repair DNA, among dozens of other cellular functions. The recommended dietary allowance for adults is 16 mg per day for men and 14 mg for women. During pregnancy, that rises to 18 mg, and during breastfeeding, 17 mg.
Most people easily meet these amounts through food. Chicken breast, tuna, turkey, lentils, and enriched grains are all rich sources. A single chicken breast provides roughly 12 mg. Deficiency is rare in developed countries and typically only shows up when overall nutrition is poor.
The Tolerable Upper Limit: 35 mg
The National Institutes of Health sets the tolerable upper intake level for supplemental niacin at 35 mg per day for adults. This ceiling was originally based on the skin flushing that nicotinic acid causes at higher doses. Niacinamide does not cause flushing, even at large doses, because it doesn’t trigger the same blood vessel dilation. Still, the 35 mg upper limit applies to both forms as a general safety threshold for the average healthy person.
For children, the limits are lower: 10 mg for ages 1 to 3, 15 mg for ages 4 to 8, 20 mg for ages 9 to 13, and 30 mg for teenagers. These apply only to supplemental niacinamide, not to amounts naturally found in food.
That said, the 35 mg ceiling is not a hard danger line. It’s a conservative guideline for the general population. Therapeutic doses used under medical supervision routinely exceed it, which brings us to the clinical uses.
Doses Used for Skin Cancer Prevention
One of the most well-studied therapeutic uses of oral niacinamide is reducing the recurrence of non-melanoma skin cancers. The landmark Australian trial (known as ONTRAC) used 500 mg twice daily, totaling 1,000 mg per day. Participants who had a history of at least two skin cancers in the previous five years saw a significant reduction in new cases while taking that dose. The British Association of Dermatologists cites this same 500 mg twice-daily regimen in its guidance for high-risk patients.
This is far above the general upper limit, but the dose was well tolerated in the study population. The protective effect disappeared after participants stopped taking it, suggesting it needs to be taken continuously to maintain benefit.
Doses Studied for Joint Health
Niacinamide has been investigated for osteoarthritis since the 1940s, with doses ranging from 900 to 4,000 mg per day, divided into multiple smaller doses throughout the day. The idea is that niacinamide’s role in cellular energy production may support cartilage repair and reduce joint inflammation. Research in this area is limited compared to the skin cancer data, and the doses are high enough that liver function monitoring is typically recommended.
Topical Niacinamide: A Different Calculation
If your search is really about niacinamide in skincare products, the math is completely different. Topical niacinamide is measured in percentages, not milligrams, and it enters the body in negligible amounts compared to oral supplements.
Concentrations of 2% have been shown to significantly reduce oil production. The most common concentration in acne and hyperpigmentation products is 5%, which is widely considered safe and effective. Some products push to 10%, though higher concentrations can cause irritation in sensitive skin without necessarily improving results. If you’re new to topical niacinamide, starting at 5% or lower and applying once daily is a reasonable approach.
How Niacinamide Differs From Niacin
People sometimes confuse niacinamide with nicotinic acid (niacin), and the distinction matters when you’re thinking about dosage. Nicotinic acid causes the well-known “niacin flush,” a hot, red, prickly feeling across the skin, at doses as low as 30 to 50 mg. This is the main reason the general upper limit was set at 35 mg. Niacinamide does not cause flushing at any dose. It also does not lower cholesterol or triglycerides the way nicotinic acid does, so if you’ve been told to take niacin for cardiovascular reasons, niacinamide is not a substitute.
Both forms satisfy your body’s basic vitamin B3 requirements equally well. The differences only emerge at higher, therapeutic doses, where each form has distinct effects and distinct side effect profiles.
Side Effects at Higher Doses
At doses below 1,000 mg per day, niacinamide is generally well tolerated. The most common complaints are mild nausea or stomach discomfort, which often improve when the supplement is taken with food or split into smaller doses throughout the day.
At doses above 3,000 mg per day, the risk of liver toxicity increases. Symptoms can include fatigue, nausea, and in rare cases, jaundice. Anyone taking high-dose niacinamide for extended periods should have liver enzymes checked periodically. This is particularly relevant for the higher end of the osteoarthritis dosing range.
During Pregnancy and Breastfeeding
Niacinamide at standard dietary and RDA-level supplement doses is considered acceptable during pregnancy and breastfeeding. Deficiency is uncommon unless overall nutrition is poor. The tolerable upper limit during pregnancy and lactation is 35 mg per day for supplemental forms, the same as for other adults. There is limited controlled data on high therapeutic doses during pregnancy, so those amounts aren’t recommended without medical guidance.
Practical Dosing Summary
- General nutrition: 14 to 16 mg per day, easily met through diet
- General upper limit for supplements: 35 mg per day
- Skin cancer prevention (high-risk patients): 500 mg twice daily (1,000 mg total)
- Osteoarthritis (in research settings): 900 to 4,000 mg per day in divided doses
- Topical skincare: 2% to 5% concentration, applied once or twice daily
The gap between the 35 mg upper limit and the 500 to 1,000 mg therapeutic doses can feel confusing. The key distinction is that the upper limit is a conservative guideline for the general public, not a toxicity threshold. Higher doses have a solid evidence base for specific conditions, but they come with a need for monitoring that the lower doses don’t require.